Hospital CEOs oppose 340B program changes, while drugmakers call for reforms
Nineteen Wisconsin health system executives signed a letter opposing changes to a federal drug discount program, but pharmaceutical companies continue to call for reforms. The executives, which include leaders from […]
To access this content, you must purchase a Premium membership, or log in if you are a member.
